Related Experiment Video
Updated: May 10, 2025

Surgical Treatment of an Endolymphatic Sac Tumor
Published on: May 26, 2023
Primary Neurolymphomatosis: A Literature Review.
Sahar Chakroun1, Alice Faucher1, Antoine Gueguen2
1Service de Physiologie Clinique-Explorations Fonctionnelles, AP-HP, DMU DREAM, Hôpital Lariboisière, Paris, France.
Primary neurolymphomatosis (PNL) is a rare condition involving lymphoma infiltration of nerves. Diagnosis is challenging, with B-cell lymphomas most common and a 45% treatment response rate.
Area of Science:
- Neurology
- Oncology
- Pathology
Background:
- Primary neurolymphomatosis (PNL) is a rare condition characterized by direct lymphomatous infiltration of the peripheral nervous system.
- Diagnosis is often delayed as the underlying hematological malignancy is not apparent at the onset of neurological symptoms.
Purpose of the Study:
- To comprehensively review published cases of PNL.
- To delineate the clinical features, diagnostic methods, progression, and treatment outcomes of PNL.
Main Methods:
- Extensive literature review of PNL cases.
- Extraction of demographic, clinical, paraclinical, treatment, and survival data.
Main Results:
- 301 cases analyzed (mean age 57.9 years, 61% male).
- Most common presentation: painless asymmetric neuropathy; other forms include radiculopathy and cranial nerve palsy.
- Diagnosis median 8 months, predominantly B-cell lymphoma (73%); 45% treatment response rate (chemotherapy, rituximab); 55% mortality.
Conclusions:
- PNL diagnosis is challenging and often delayed.
- B-cell lymphomas are the most frequent cause.
- Limited treatment efficacy and high mortality underscore the need for further research.
More Related Videos
07:36Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
Published on: May 1, 2015
06:44Author Spotlight: Unveiling Cellular Functions and Potential Clinical Implications of Leptomeningeal Lymphatic Endothelial Cells
Published on: September 8, 2023